DROXIA
NDC 80725-830, Hydroxyurea, capsule, from Waylis Therapeutics LLC.
- Product NDC
- 80725-830
- Status
- Listed
- Labeler
- Waylis Therapeutics LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA016295
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80725-830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROXYUREA300 mg/1
Pharmacologic classes
Antimetabolite [EPC]; Urea [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80725-830-60 | 80725083060 | 60 CAPSULE in 1 BOTTLE (80725-830-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4ad13dc6-a2ab-4308-96b3-7c642c92cc23
Use it
Look up 80725-830 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80725-830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80725-830. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.